
"It is good to have a simple two-pricing structure, one for the government and another for the private sector. The centralised procurement will allow states to focus just on vaccination rather than getting into bidding processes and procuring vaccines from manufacturers which is not their job, the Biocon founder said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3iqbfld
via
IFTTT
0 comments:
Post a Comment